The Koch Institute for Integrative Cancer Research at MIT

Mosaic of colored tiles and images of research and people

Celebrating 50 years of collaboration, innovation, and curiosity in cancer research at MIT

Join us 

Our Research Areas

From fundamental discoveries to engineering advances, we strategically pursue five areas of research that, across tumor types, are critical for rapid progress toward defeating cancer.

Detection & monitoring  
Metastasis  
Immunology & immunotherapy  
Nano-based drugs  
Precision medicine  

News

Langer named Kavli Laureate

MIT News

June 12, 2024

Congratulations to Robert Langer, who received a 2024 Kavli Prize in Nanoscience! The award recognizes his innovations in engineered  nanomaterials for the controlled release of drugs and nanoparticles for the delivery of vaccines. Langer’s work has had immense impact on the treatment of a range of diseases including cancer and schizophrenia and was instrumental in the development of mRNA vaccines. 

An enhanced view of gene transcription

MIT News

Sharp Lab researchers led by postdoc D.B. Jay Mahat invented a technique to observe coordination of gene expression and enhancer activation.

RNAi: An MIT case study

MIT News

Alnylam Pharmaceuticals, co-founded by Phillip Sharp, has turned the promise of RNAi research into a new class of powerful therapies.

More News 

At the Koch Institute for Integrative Cancer Research, scientists and engineers work together to solve some of the most difficult problems in cancer. We ask big questions in strategic areas, where the answers have big impacts on how we understand and treat cancer.